GlassScriptPhysician profile
Meghan M Cooley
NPI 1851730238
$1,291.21
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,291.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $282.43 | 2021 | |
| Lilly USA, LLC | $154.06 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $133.46 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $73.77 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $62.65 | 2021 | |
| Janssen Pharmaceuticals, INC | $59.71 | 2021 | |
| Amgen INC. | $53.99 | 2021 | |
| Pfizer INC. | $48.76 | 2021 | |
| Amarin Pharma, INC. | $42.81 | 2021 | |
| Novo Nordisk INC | $38.93 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $37.88 | 2021 | |
| Merck Sharp & Dohme LLC | $36.82 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $29.46 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $29.34 | 2021 | |
| Adlon Therapeutics L.P. | $26.58 | 2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $24.33 | 2021 | |
| Daiichi Sankyo INC. | $20.84 | 2021 | |
| Allergan, INC. | $20.36 | 2021 | |
| Esperion Therapeutics, INC. | $17.13 | 2021 | |
| Upsher-Smith Laboratories LLC | $16.81 | 2021 | |
| Jazz Pharmaceuticals INC. | $14.79 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $14.77 | 2021 | |
| Therapeuticsmd, INC. | $13.36 | 2021 | |
| Astellas Pharma US INC | $13.20 | 2021 | |
| Eisai INC. | $12.59 | 2021 | |
| Sunovion Pharmaceuticals INC. | $12.38 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meghan Cooley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.